openPR Logo
Press release

United States Epistaxis Device Market Soars: Innovations Driving Safer & Faster Nosebleed Treatments in 2025 | Key players - Smith & Nephew, Stryker Corp, Teleflex Incorporated.

10-23-2025 02:03 PM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Epistaxis Device Market

Epistaxis Device Market

Market Overview:

The Epistaxis Device Market is estimated to reach at a CAGR 5.2% during the forecast period (2024-2031). The Market is growing due to the rising prevalence of nosebleeds, increasing awareness of minimally invasive treatments, and advancements in hemostatic and nasal packing technologies.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/epistaxis-device-market?sz

The Epistaxis Device Market refers to the global industry focused on the development, manufacturing, and commercialization of medical devices designed to prevent, manage, or treat nosebleeds (epistaxis). These devices include nasal tampons, balloon catheters, and hemostatic agents, serving hospitals, ENT clinics, and emergency care settings. Market growth is driven by rising ENT disorders, technological advancements, and increasing patient awareness.

Industry Recent Developments:

United States:

✅ The US Epistaxis Device Market is expanding, driven by rising prevalence of nasal bleeding disorders, increased adoption of advanced hemostatic and nasal packing devices, and growing awareness of minimally invasive treatment options. Homecare devices are emerging rapidly alongside hospital and clinical use (September 2025).

✅ Key players like Medtronic, Smith & Nephew, and DeRoyal Industries are advancing minimally invasive epistaxis treatment technologies, enhancing efficacy and patient comfort in the market (September 2025).

Japan:

✅ Japan's healthcare market emphasizes high-quality, precision medical devices suggesting growing adoption of advanced, minimally invasive epistaxis treatments and innovative hemostatic products (September 2025).

✅ The Japanese rapid rhino epistaxis device segment continues to grow due to rising recognition of effective nasal bleeding treatments in clinics and hospitals (October 2025).

✅ Increasing healthcare infrastructure investment and rising awareness about nasal bleeding management in Japan create opportunities for expanded market penetration of advanced epistaxis devices (October 2025).

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/epistaxis-device-market?sz

FDA Approvals and Regulatory Developments:

1. King Pharmaceuticals - THROMBIN-JMI Epistaxis Kit
King Pharmaceuticals received FDA approval for its THROMBIN-JMI Epistaxis Kit, an intranasal spray delivery device designed to treat nosebleeds. This approval marks a significant advancement in epistaxis management, offering a new treatment option for patients.

2. ARS Pharmaceuticals - neffy® 1 mg
ARS Pharmaceuticals announced the FDA approval of neffy® 1 mg, the first and only needle-free epinephrine treatment approved for younger children. This approval provides a non-invasive alternative for treating severe allergic reactions in pediatric patients.

3. FDA Exemptions for Epistaxis Devices
The FDA has exempted most Class I epistaxis devices, such as epistaxis balloons, from premarket notification requirements under 21 CFR Parts 862-892. Manufacturers of these devices are still required to register their establishments and comply with certain general controls.

Mergers and Acquisitions:

The epistaxis device market has witnessed moderate M&A activity in 2025:

CoagCo LLC and CHAMPS Group Purchasing Partnership: In June 2024, CoagCo LLC, a Cleveland-based medical device company, partnered with CHAMPS Group Purchasing to enhance the distribution of its innovative nosebleed device across 20,000 U.S. member locations.

Market Consolidation: The market remains moderately concentrated, with key players like Medtronic, Smith & Nephew, Johnson & Johnson (Ethicon), Stryker, Cook Group, Olympus, Boston Scientific, Karl Storz, and AbbVie leading the charge.

Major Key Players:

Smith & Nephew
Stryker Corp
Teleflex Incorporated
SPIGGLE & THEIS Medizintechnik GmbH
Summit Medical LLC.
EON Meditech.

Segments Covered in the Epistaxis Device Market:

By Product Type: Nasal Catheters, Nasal Tampons, Others.

By Application: Anterior epistaxis, Posterior epistaxis.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=epistaxis-device-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Epistaxis Device market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Epistaxis Device Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Epistaxis Device market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Epistaxis Device Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Epistaxis Device Market in 2025?
◆ What is the projected growth rate of the Epistaxis Device Market through 2033?
◆ Who are the key players in the Epistaxis Device Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Epistaxis Device Market Soars: Innovations Driving Safer & Faster Nosebleed Treatments in 2025 | Key players - Smith & Nephew, Stryker Corp, Teleflex Incorporated. here

News-ID: 4236233 • Views:

More Releases from DataM Intelligence 4Market Research

United States Omega-3 Market is expected to reach US$ 4.85 billion by 2032 | Major key players - Polaris, BASF SE, ADM.
United States Omega-3 Market is expected to reach US$ 4.85 billion by 2032 | Maj …
Market Size and Forecast: The Global Omega-3 Market size reached US$ 2.64 billion in 2024 and is expected to reach US$ 4.85 billion by 2032, growing with a CAGR of 7.92% during the forecast period 2025-2032. The Market is growing due to increasing consumer awareness of heart, brain, and joint health benefits, alongside rising demand for dietary supplements and functional foods. Get a Free Sample PDF Of This Report (Get Higher Priority
United States CRISPR Gene Editing Market is expected to reach US$ 12.78 billion by 2033 | Major key players - Thermo Fisher Scientific Inc., Lonza Bioscience, QIAGEN.
United States CRISPR Gene Editing Market is expected to reach US$ 12.78 billion …
Market Size and Growth: The Global CRISPR Gene Editing Market size reached US$ 4.21 Billion in 2023 with a rise of US$ 4.67 Billion in 2024 and is expected to reach US$ 12.78 Billion by 2033, growing at a CAGR of 11.9% during the forecast period 2025-2033. The Market is growing due to increasing adoption of gene therapies, rising prevalence of genetic disorders, and advances in biotechnology enabling precise and cost-effective
United States Postpartum Hemorrhage Treatment Market Poised for Rapid Growth: Innovative Therapies Driving 2025 | Top key players - Teleflex Incorporated, OBSTETRX, BACTIGUARD AB.
United States Postpartum Hemorrhage Treatment Market Poised for Rapid Growth: In …
Market Overview: The Global Postpartum Hemorrhage Treatment Market is expected to reach at a Significant CAGR during the forecast period 2024-2031. The Postpartum Hemorrhage Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research
United States Primary Hyperoxaluria Treatment Market is expected to reach US$ 365.49 million by 2031 | Top key players - Pfizer Inc., Novo Nordisk A/S, Merck KGaA.
United States Primary Hyperoxaluria Treatment Market is expected to reach US$ 36 …
Market Size and Forecast: The Global Primary Hyperoxaluria Treatment Market size reached US$ 168.96 million in 2023 and is expected to reach US$ 365.49 million by 2031, growing at a CAGR of 9.8% during the forecast period 2024-2031. The Market is growing due to rising prevalence of the disorder and increasing adoption of advanced therapies. Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/primary-hyperoxaluria-treatment-market?sz The Primary

All 5 Releases


More Releases for Epistaxis

Epistaxis Drugs Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Epistaxis Drugs Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion. The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key players in
Epistaxis Device market foreseen to grow exponentially over 2017-2026
According to Stratistics MRC, the Global Epistaxis Device market is accounted for $17,848.91 thousands in 2017 and is expected to reach $34,508.19 thousands by 2026 growing at a CAGR of 7.6% during the forecast period. Some of the key factors such as increasing incidences of the dry nasal membrane and abnormal nosebleeds are expected to boost demand for the market. Moreover, the side effects such as pain, swelling and running
Epistaxis Market UpComing Developments With Major Key Players
The global epistaxis market was valued at US$ 130.0 million in 2016 and is expected to witness a CAGR of 5.7% during the forecast period (2017 – 2025). Rising cases of cardiovascular disorders, mainly hypertensive diseases, which are highly susceptible to hemorrhage are the leading causes of epistaxis. According to the Medical Statistics of World Health Organization in 2015, there were approximately 289,000 cases of hypertension recorded among pregnant women. According
Epistaxis Market to Witness an Outstanding Growth by 2026
Growing prevalence of hypertension is expected to impact the global epistaxis market. Instances of dry mucous membrane attributed to extreme weather conditions will continue to rev up demand for epistaxis products globally. This Market Research report analyzes the expansion of global epistaxis market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026. Download Sample Copy of this report @ https://www.xploremr.com/connectus/sample/1819 Scope The scope of Market
09-03-2018 | Health & Medicine
Fact.MR
Epistaxis Market Research Report: Examined by Size, Trends, Share and Leading Su …
Growing prevalence of hypertension is expected to impact the global epistaxis market. Instances of dry mucous membrane attributed to extreme weather conditions will continue to rev up demand for epistaxis products globally. This FactMR report analyzes the expansion of global epistaxis market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026. The scope of FactMR’s report is to analyze the global Epistaxis
Epistaxis Market Industry Forecast till 2025
Epistaxis, also known as nosebleed, occurs due to rupturing of a small blood vessel in the lining of nose, as the interior of the nose is highly delicate and sensitive and could not tolerate certain factors that make them fragile and prone to burst resulting in bleeding. Nosebleeds are common mostly during winter, as more of the upper respiratory infections occur during this season. Request Sample Copy of this Business Report